Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID): Molecular Pathogenesis and Clinical Manifestations.

about

Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID): Molecular Pathogenesis and Clinical Manifestations.

Item

http://www.wikidata.org/entity/Q45871226

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Adenosine Deaminase (ADA)-Defi ...... s and Clinical Manifestations.

@en

Adenosine Deaminase

@nl

type

Item

label

Adenosine Deaminase (ADA)-Defi ...... s and Clinical Manifestations.

@en

Adenosine Deaminase

@nl

prefLabel

Adenosine Deaminase (ADA)-Defi ...... s and Clinical Manifestations.

@en

Adenosine Deaminase

@nl

P1476

Adenosine Deaminase (ADA)-Defi ...... s and Clinical Manifestations.

@en

P2093

Denise A Carbonaro-Sarracino

http://www.w3.org/2001/XMLSchema#string

Donald B Kohn

http://www.w3.org/2001/XMLSchema#string

Federico A Moretti

http://www.w3.org/2001/XMLSchema#string

Hubert B Gaspar

http://www.w3.org/2001/XMLSchema#string

Kathryn L Bradford

http://www.w3.org/2001/XMLSchema#string

P2860

Direct association of adenosine deaminase with a T cell activation antigen, CD26

New assignment of the adenosine deaminase gene locus to chromosome 20q13 X 11 by study of a patient with interstitial deletion 20q.

Identification of a point mutation resulting in a heat-labile adenosine deaminase (ADA) in two unrelated children with partial ADA deficiency

Adenosine Deaminase Deficiency - More Than Just an Immunodeficiency

Mutations in genes required for T-cell development: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review

Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution

Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling

Adenosine kinase inhibition promotes survival of fetal adenosine deaminase-deficient thymocytes by blocking dATP accumulation

Adenosine deaminase-deficient mice generated using a two-stage genetic engineering strategy exhibit a combined immunodeficiency

Adenosine-deaminase-deficient mice die perinatally and exhibit liver-cell degeneration, atelectasis and small intestinal cell death

P2888

s10875-017-0433-3

P304

626-637

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10875-017-0433-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091352715

http://www.w3.org/2001/XMLSchema#string

P698

28842866

http://www.w3.org/2001/XMLSchema#string